Skip to main content
Top
Published in: Breast Cancer Research 1/2018

Open Access 01-12-2018 | Research article

Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds

Authors: Chao Wang, Adam R. Brentnall, Jack Cuzick, Elaine F. Harkness, D. Gareth Evans, Susan Astley

Published in: Breast Cancer Research | Issue 1/2018

Login to get access

Abstract

Background

The percentage of mammographic dense tissue (PD) defined by pixel value threshold is a well-established risk factor for breast cancer. Recently there has been some evidence to suggest that an increased threshold based on visual assessment could improve risk prediction. It is unknown, however, whether this also applies to volumetric density using digital raw mammograms.

Method

Two case-control studies nested within a screening cohort (ages of participants 46–73 years) from Manchester UK were used. In the first study (317 cases and 947 controls) cases were detected at the first screen; whereas in the second study (318 cases and 935 controls), cases were diagnosed after the initial mammogram. Volpara software was used to estimate dense tissue height at each pixel point, and from these, volumetric and area-based PD were computed at a range of thresholds. Volumetric and area-based PDs were evaluated using conditional logistic regression, and their predictive ability was assessed using the Akaike information criterion (AIC) and matched concordance index (mC).

Results

The best performing volumetric PD was based on a threshold of 5 mm of dense tissue height (which we refer to as VPD5), and the best areal PD was at a threshold level of 6 mm (which we refer to as APD6), using pooled data and in both studies separately. VPD5 showed a modest improvement in prediction performance compared to the original volumetric PD by Volpara with ΔAIC = 5.90 for the pooled data. APD6, on the other hand, shows much stronger evidence for better prediction performance, with ΔAIC = 14.52 for the pooled data, and mC increased slightly from 0.567 to 0.577.

Conclusion

These results suggest that imposing a 5 mm threshold on dense tissue height for volumetric PD could result in better prediction of cancer risk. There is stronger evidence that area-based density with a 6 mm threshold gives better prediction than the original volumetric density metric.
Appendix
Available only for authorised users
Literature
1.
go back to reference Assi V, Warwick J, Cuzick J, Duffy SW. Clinical and epidemiological issues in mammographic density. Nat Rev Clin Oncol. 2012;9(1):33–40.CrossRef Assi V, Warwick J, Cuzick J, Duffy SW. Clinical and epidemiological issues in mammographic density. Nat Rev Clin Oncol. 2012;9(1):33–40.CrossRef
2.
go back to reference Hopper JL. Odds per adjusted standard deviation: comparing strengths of associations for risk factors measured on different scales and across diseases and populations. Am J Epidemiol. 2015;182(10):863–7.CrossRefPubMedPubMedCentral Hopper JL. Odds per adjusted standard deviation: comparing strengths of associations for risk factors measured on different scales and across diseases and populations. Am J Epidemiol. 2015;182(10):863–7.CrossRefPubMedPubMedCentral
3.
go back to reference Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative-analysis of mammographic densities. Phys Med Biol. 1994;39(10):1629–38.CrossRefPubMed Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative-analysis of mammographic densities. Phys Med Biol. 1994;39(10):1629–38.CrossRefPubMed
4.
go back to reference Nguyen TL, Aung YK, Evans CF, Yoon-Ho C, Jenkins MA, Sung J, Hopper JL, Song Y-M. Mammographic density defined by higher than conventional brightness threshold better predicts breast cancer risk for full-field digital mammograms. Breast Cancer Res. 2015;17:1-9. Nguyen TL, Aung YK, Evans CF, Yoon-Ho C, Jenkins MA, Sung J, Hopper JL, Song Y-M. Mammographic density defined by higher than conventional brightness threshold better predicts breast cancer risk for full-field digital mammograms. Breast Cancer Res. 2015;17:1-9.
5.
go back to reference Nguyen TL, Choi Y-H, Aung YK, Evans CF, Trinh NH, Li S, Dite GS, Kim MS, Brennan PC, Jenkins MA, et al. Breast cancer risk associations with digital mammographic Density by pixel brightness threshold and mammographic system. Radiology. 2018;286(2):433–42. Nguyen TL, Choi Y-H, Aung YK, Evans CF, Trinh NH, Li S, Dite GS, Kim MS, Brennan PC, Jenkins MA, et al. Breast cancer risk associations with digital mammographic Density by pixel brightness threshold and mammographic system. Radiology. 2018;286(2):433–42.
6.
go back to reference Nguyen TL, Aung YK, Evans CF, Dite GS, Stone J, MacInnis RJ, Dowty JG, Bickerstaffe A, Aujard K, Rommens JM, et al. Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk. Int J Epidemiol. 2016;46(2):652–61. Nguyen TL, Aung YK, Evans CF, Dite GS, Stone J, MacInnis RJ, Dowty JG, Bickerstaffe A, Aujard K, Rommens JM, et al. Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk. Int J Epidemiol. 2016;46(2):652–61.
7.
go back to reference Highnam R, Brady SM, Yaffe MJ, Karssemeijer N, Harvey J. Robust breast composition measurement - VolparaTM. In: Martí J, Oliver A, Freixenet J, Martí R, editors. Digital mammography: 10th International Workshop, IWDM 2010, Girona, Catalonia, Spain, June 16–18, 2010 Proceedings. Berlin: Springer Berlin Heidelberg; 2010. p. 342–9.CrossRef Highnam R, Brady SM, Yaffe MJ, Karssemeijer N, Harvey J. Robust breast composition measurement - VolparaTM. In: Martí J, Oliver A, Freixenet J, Martí R, editors. Digital mammography: 10th International Workshop, IWDM 2010, Girona, Catalonia, Spain, June 16–18, 2010 Proceedings. Berlin: Springer Berlin Heidelberg; 2010. p. 342–9.CrossRef
8.
go back to reference Ciatto S, Bernardi D, Calabrese M, Durando M, Gentilini MA, Mariscotti G, Monetti F, Moriconi E, Pesce B, Roselli A, et al. A first evaluation of breast radiological density assessment by QUANTRA software as compared to visual classification. Breast. 2012;21(4):503–6.CrossRefPubMed Ciatto S, Bernardi D, Calabrese M, Durando M, Gentilini MA, Mariscotti G, Monetti F, Moriconi E, Pesce B, Roselli A, et al. A first evaluation of breast radiological density assessment by QUANTRA software as compared to visual classification. Breast. 2012;21(4):503–6.CrossRefPubMed
9.
go back to reference Eng A, Gallant Z, Shepherd J, McCormack V, Li J, Dowsett M, Vinnicombe S, Allen S, Dos-Santos-Silva I. Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods. Breast Cancer Res. 2014;16:1-12. Eng A, Gallant Z, Shepherd J, McCormack V, Li J, Dowsett M, Vinnicombe S, Allen S, Dos-Santos-Silva I. Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods. Breast Cancer Res. 2014;16:1-12.
10.
go back to reference Evans DGR, Warwick J, Astley SM, Stavrinos P, Sahin S, Ingham S, McBurney H, Eckersley B, Harvie M, Wilson M, et al. Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention. Cancer Prev Res. 2012;5(7):943–51.CrossRef Evans DGR, Warwick J, Astley SM, Stavrinos P, Sahin S, Ingham S, McBurney H, Eckersley B, Harvie M, Wilson M, et al. Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention. Cancer Prev Res. 2012;5(7):943–51.CrossRef
11.
go back to reference Wang C, Brentnall AR, Cuzick J, Harkness EF, Evans DG, Astley S. A novel and fully automated mammographic texture analysis for risk prediction: results from two case-control studies. Breast Cancer Res. 2017;19:1-13. Wang C, Brentnall AR, Cuzick J, Harkness EF, Evans DG, Astley S. A novel and fully automated mammographic texture analysis for risk prediction: results from two case-control studies. Breast Cancer Res. 2017;19:1-13.
12.
go back to reference Astley SM, Harkness EF, Sergeant JC, Warwick J, Stavrinos P, Warren R, Wilson M, Beetles U, Gadde S, Lim Y, et al. A comparison of five methods of measuring mammographic density: a case-control study. Breast Cancer Res. 2018;20:1-13. Astley SM, Harkness EF, Sergeant JC, Warwick J, Stavrinos P, Warren R, Wilson M, Beetles U, Gadde S, Lim Y, et al. A comparison of five methods of measuring mammographic density: a case-control study. Breast Cancer Res. 2018;20:1-13.
13.
go back to reference Brentnall AR, Cuzick J, Field J, Duffy SW. A concordance index for matched case-control studies with applications in cancer risk. Stat Med. 2015;34(3):396–405.CrossRefPubMed Brentnall AR, Cuzick J, Field J, Duffy SW. A concordance index for matched case-control studies with applications in cancer risk. Stat Med. 2015;34(3):396–405.CrossRefPubMed
14.
go back to reference Burnham KP, Anderson DR, Huyvaert KP. AIC model selection and multimodel inference in behavioral ecology: some background, observations, and comparisons. Behav Ecol Sociobiol. 2011;65(1):23–35.CrossRef Burnham KP, Anderson DR, Huyvaert KP. AIC model selection and multimodel inference in behavioral ecology: some background, observations, and comparisons. Behav Ecol Sociobiol. 2011;65(1):23–35.CrossRef
15.
16.
go back to reference Otsuka M, Harkness EF, Chen X, Moschidis E, Bydder M, Gadde S, Lim YY, Maxwell AJ, Evans GD, Howell A, et al. Local mammographic density as a predictor of breast cancer. In: Proc. SPIE 9414, Medical Imaging 2015: Computer-Aided Diagnosis, 941417 (20 March 2015). Otsuka M, Harkness EF, Chen X, Moschidis E, Bydder M, Gadde S, Lim YY, Maxwell AJ, Evans GD, Howell A, et al. Local mammographic density as a predictor of breast cancer. In: Proc. SPIE 9414, Medical Imaging 2015: Computer-Aided Diagnosis, 941417 (20 March 2015).
17.
go back to reference Brandt KR, Scott CG, Ma L, Mahmoudzadeh AP, Jensen MR, Whaley DH, Wu FF, Malkov S, Hruska CB, Norman AD, et al. Comparison of clinical and automated breast density measurements: implications for risk prediction and supplemental screening. Radiology. 2016;279(3):710–9.CrossRefPubMed Brandt KR, Scott CG, Ma L, Mahmoudzadeh AP, Jensen MR, Whaley DH, Wu FF, Malkov S, Hruska CB, Norman AD, et al. Comparison of clinical and automated breast density measurements: implications for risk prediction and supplemental screening. Radiology. 2016;279(3):710–9.CrossRefPubMed
18.
go back to reference Nickson C, Arzhaeva Y, Aitken Z, Elgindy T, Buckley M, Li M, English DR, Kavanagh AM. AutoDensity: an automated method to measure mammographic breast density that predicts breast cancer risk and screening outcomes. Breast Cancer Res. 2013;15:1-11. Nickson C, Arzhaeva Y, Aitken Z, Elgindy T, Buckley M, Li M, English DR, Kavanagh AM. AutoDensity: an automated method to measure mammographic breast density that predicts breast cancer risk and screening outcomes. Breast Cancer Res. 2013;15:1-11.
19.
go back to reference Jeffers AM, Sieh W, Lipson JA, Rothstein JH, McGuire V, Whittemore AS, Rubin DL. Breast Cancer risk and mammographic density assessed with semiautomated and fully automated methods and BI-RADS. Radiology. 2017;282(2):348–55.CrossRefPubMed Jeffers AM, Sieh W, Lipson JA, Rothstein JH, McGuire V, Whittemore AS, Rubin DL. Breast Cancer risk and mammographic density assessed with semiautomated and fully automated methods and BI-RADS. Radiology. 2017;282(2):348–55.CrossRefPubMed
22.
go back to reference van Veen EM, Brentnall AR, Byers H, et al. Use of single-nucleotide polymorphisms and mammographic density plus classic risk factors for breast cancer risk prediction. JAMA Oncol. 2018;4(4):476–82. van Veen EM, Brentnall AR, Byers H, et al. Use of single-nucleotide polymorphisms and mammographic density plus classic risk factors for breast cancer risk prediction. JAMA Oncol. 2018;4(4):476–82.
Metadata
Title
Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds
Authors
Chao Wang
Adam R. Brentnall
Jack Cuzick
Elaine F. Harkness
D. Gareth Evans
Susan Astley
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2018
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-018-0979-x

Other articles of this Issue 1/2018

Breast Cancer Research 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine